FdaApplication
ANDA 216977
Identifiers
- fda_app_no: ANDA216977
Properties
| Property | Value |
|---|---|
| applicant_name | BPI LABS LLC |
| application_type | ANDA |
| approval_date | 2023-10-06 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| NALOXONE HYDROCHLORIDE | NALOXONE HYDROCHLORIDE | 1MG/ML | INJECTABLE;INJECTION |
1 product